Resolve BioSciences

About:

Resolve Biosciences is a biotechnology research company for molecular cartography.

Website: https://resolvebiosciences.com/

Top Investors: EDBI, HTGF | High-Tech Gruenderfonds, Patient Square Capital, NRW.BANK, Alafi Capital

Description:

Resolve Biosciences provides bioinformatics, imaging, spatial biology, genomics, gene expression, transcriptomics, histology, pathology, single cell, neuroscience, infectious diseases, oncology, toxicology, microscopy, neuroscience, agrigenomics, cell atlasing, and single-cell services. An online inquiry form is available on the company's website.

Total Funding Amount:

$95M

Headquarters Location:

Düsseldorf, Nordrhein-Westfalen, Germany

Founded Date:

2020-12-10

Contact Email:

info(AT)resolvebiosciences.com

Founders:

Jason T. Gammack, Peer M. Schatz

Number of Employees:

51-100

Last Funding Date:

2022-10-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai